공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 통증 관리약 시장 : 업계 동향, 시장 점유율, 규모, 성장률, 기회, 예측(2021-2026년)

Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

리서치사 IMARC Services Private Limited
발행일 2021년 04월 상품 코드 999842
페이지 정보 영문 108 Pages
가격
US $ 2,299 ₩ 2,638,000 PDF (Single User License)
US $ 3,399 ₩ 3,900,000 PDF (5 User License)
US $ 4,499 ₩ 5,162,000 PDF (Corporate License)


세계의 통증 관리약 시장 : 업계 동향, 시장 점유율, 규모, 성장률, 기회, 예측(2021-2026년) Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
발행일 : 2021년 04월 페이지 정보 : 영문 108 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 통증 관리약 시장 규모는 2020년 740억 달러에 달했습니다. 통증 관리약은 통증 수용체에 약리학적 작용을 수행하고, 불편함을 유발하는 증상에 대항하는 작용을 합니다. 이들 약은 각기 다른 생리 기능을 통해 작용함으로써 골관절염, 만성관절염, 당뇨병성 신경증, 다발성 경화증, 암 등 다양한 건강 문제로 인한 통증을 완화시켜줍니다. 최근 몇 년 동안, 의학 발전에 따라, 통증 관리를 개선하는 새로운 조합과 새로운 약물 전달 기술이 도입되었습니다.

세계 시장 성장을 견인하는 주요 요인 중 하나는 전 세계적으로 노인 인구가 증가하고있는 것입니다. 2018년 60세 이상 인구는 약 9억 9,100만명이었습니다. 이 인구는 2024년까지 11억 8,000만 명에 달할 것으로 예측되어집니다. 만성 통증의 유병률은 노인에게서 현저하게 높으며, 이에 따라 통증 관리약 수요는 전 세계적으로 확대되고 있습니다. 또한 입원 증례수 증가와 효과적인 neuropathic 고통 관리 약물의 수요와 공급에 대한 큰 격차에서 비롯된 혁신적이고 선진적인 치료법과 의약품이 등장하고 있습니다. 또한 대형 제약 기업들은 보다 안전하고보다 효과적이고 경제적이며 관리가 쉬운 진통제를 개발하기 위한 연구 개발(R&D) 활동에 많은 투자를 하고 있습니다. 의료비 증가, 연구 개발 개선, 소비자 의식 고양, 의료 서비스 개선에 대한 정부 지원 등 기타 요인이 시장 성장을 뒷받침하고 있습니다. 세계의 통증 관리약 시장은 2021년에서 2026년까지 예측 기간 동안 완만한 성장세를 보일 것으로 예상됩니다.

세계의 통증 관리약(Pain Management Drugs) 시장에 대해 조사했으며, 업계 동향/시장 예측/약물 클래스·적응증·유통 채널·지역별 시장 분석/경쟁 상황/주요 기업 개요 등 정보를 제공합니다.

목차

제1장 서문

제2장 범위 및 조사 방법

제3장 개요

제4장 서론

제5장 세계의 통증 관리약 시장

  • 시장 개요
  • 시장 실적
  • COVID-19의 영향
  • 약물 클래스별 시장 세분화
  • 적응증별 시장 세분화
  • 유통 채널별 시장 세분화
  • 지역별 시장 세분화

제6장 약물 클래스별 시장 세분화

  • NSAID
  • 마취
  • 항경련약물
  • 항편두통제
  • 항우울제
  • 오피오이드
  • 기타

제7장 적응증별 시장 세분화

  • 근골격 통증
  • 수술 및 외상 통증
  • 암 통증
  • neuropathic 고통
  • 편두통
  • 분만 통증
  • 섬유근통
  • 작열 통증
  • 치과/안면 통증
  • 소아의 통증
  • 기타

제8장 유통 채널별 시장 세분화

  • 병원 약국
  • 소매 약국
  • 온라인 약국

제9장 지역별 시장 세분화

  • 북미
  • 유럽
  • 아시아 태평양 지역
  • 중동 및 아프리카
  • 남미

제10장 SWOT 분석

제11장 가치 사슬 분석

제12장 포터의 5세력 모델 분석

제13장 가격 분석

  • 가격 지표
  • 가격 구조
  • 마진 분석

제14장 경쟁 상황

  • 시장 구조
  • 주요 기업
  • 주요 기업 개요
    • Abbott Laboratories, Inc.
    • Pfizer, Inc.
    • Eli Lilly&Company
    • Endo International plc
    • F. Hoffmann-La Roche AG
    • Bausch Health Companies, Inc.
    • Merck&Co. Inc.
    • Allergen Inc.
    • Novartis International AG
    • Johnson&Johnson Private Limited
    • GlaxoSmithKline Plc
    • Purdue Pharma LP
LYJ 21.04.30

List of Figures

  • Figure 1: Global: Pain Management Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Pain Management Drugs Market: Sales Value (in Billion US$), 2015 - 2020
  • Figure 3: Global: Pain Management Drugs Market: Breakup by Drug Class (in %), 2020
  • Figure 4: Global: Pain Management Drugs Market: Breakup by Indication (in %), 2020
  • Figure 5: Global: Pain Management Drugs Market: Breakup by Distribution Channel (in %), 2020
  • Figure 6: Global: Pain Management Drugs Market: Breakup by Region (in %), 2020
  • Figure 7: Global: Pain Management Drugs Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 8: Global: Pain Management Drugs Industry: SWOT Analysis
  • Figure 9: Global: Pain Management Drugs Industry: Value Chain Analysis
  • Figure 10: Global: Pain Management Drugs Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Pain Management Drugs (NSAIDs) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Pain Management Drugs (NSAIDs) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Pain Management Drugs (Anesthetics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Pain Management Drugs (Anesthetics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Pain Management Drugs (Anticonvulsants) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Pain Management Drugs (Anticonvulsants) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Pain Management Drugs (Antimigraine Agents) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Pain Management Drugs (Antimigraine Agents) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Pain Management Drugs (Antidepressants) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Pain Management Drugs (Antidepressants) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Pain Management Drugs (Opioids) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Pain Management Drugs (Opioids) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Pain Management Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Pain Management Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Pain Management Drugs (Musculoskeletal Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Pain Management Drugs (Musculoskeletal Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Pain Management Drugs (Surgical and Trauma Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Pain Management Drugs (Surgical and Trauma Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 29: Global: Pain Management Drugs (Cancer Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Pain Management Drugs (Cancer Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Pain Management Drugs (Neuropathic Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Pain Management Drugs (Neuropathic Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Pain Management Drugs (Migraine Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Pain Management Drugs (Migraine Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Pain Management Drugs (Obstetrical Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Global: Pain Management Drugs (Obstetrical Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Global: Pain Management Drugs (Fibromyalgia Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Global: Pain Management Drugs (Fibromyalgia Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: Global: Pain Management Drugs (Burn Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: Global: Pain Management Drugs (Burn Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: Global: Pain Management Drugs (Dental/Facial Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Global: Pain Management Drugs (Dental/Facial Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: Global: Pain Management Drugs (Pediatric Pain) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: Global: Pain Management Drugs (Pediatric Pain) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: Global: Pain Management Drugs (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: Global: Pain Management Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: Global: Pain Management Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2015 & 2020
  • Figure 48: Global: Pain Management Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2021-2026
  • Figure 49: Global: Pain Management Drugs Market: Sales through Retail Pharmacies (in Million US$), 2015 & 2020
  • Figure 50: Global: Pain Management Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2021-2026
  • Figure 51: Global: Pain Management Drugs Market: Sales through Online Pharmacies (in Million US$), 2015 & 2020
  • Figure 52: Global: Pain Management Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2021-2026
  • Figure 53: North America: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: North America: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: Europe: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: Europe: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: Asia Pacific: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: Asia Pacific: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: Middle East and Africa: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: Middle East and Africa: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Latin America: Pain Management Drugs Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Latin America: Pain Management Drugs Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Pain Management Drugs Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Pain Management Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
  • Table 3: Global: Pain Management Drugs Market Forecast: Breakup by Indication (in Million US$), 2021-2026
  • Table 4: Global: Pain Management Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
  • Table 5: Global: Pain Management Drugs Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: Pain Management Drugs Market Structure
  • Table 7: Global: Pain Management Drugs Market: Key Players

The global pain management drugs market reached a value of US$ 74 Billion in 2020. Pain management drugs perform pharmacological actions on pain receptors and work against discomfort-causing symptoms. These medications provide relief from the distressing feeling caused due to various health issues, such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis and cancer, by acting through different physiological functions. In recent years, medical advancements have led to the introduction of novel combinations and newer drug delivery techniques that provide improved pain management.

One of the key factors driving the global market is the rising geriatric population across the globe. In 2018, the population of people aged 60 years and above was around 991 million. This population is projected to reach 1.18 billion by 2024. With the prevalence of chronic pain being significantly higher in older adults, the demand for pain management drugs is escalating across the globe. Furthermore, a rise in the number of hospitalization cases and a huge demand-supply gap for effective neuropathic pain management drugs have led to the emergence of innovative and advanced therapies and medicines. Moreover, the leading pharmaceutical companies are investing heavily in research and development (R&D) activities to develop analgesics or painkillers that are safer, more effective, economically viable and easier to administer. Other factors, including rising healthcare expenditure, improving R&D, increasing consumer awareness, and significant government support for improving healthcare services, are driving the growth of the market. Looking forward, IMARC Group expects the global pain management drugs market to exhibit moderate growth during the forecast period (2021-2026).

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global pain management drugs market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region,drug class, indication and distribution channel.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Drug Class:

  • NSAIDs
  • Anesthetics
  • Anticonvulsants
  • Antimigraine Agents
  • Antidepressants
  • Opioids
  • Others

Market Breakup by Indication:

  • Musculoskeletal Pain
  • Surgical and Trauma Pain
  • Cancer Pain
  • Neuropathic Pain
  • Migraine Pain
  • Obstetrical Pain
  • Fibromyalgia Pain
  • Burn Pain
  • Dental/Facial Pain
  • Pediatric Pain
  • Others

Market Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the pain management drugs companies being Abbott Laboratories, Inc., Pfizer, Inc., Eli Lilly & Company, Endo International plc, F. Hoffmann-La Roche AG, Bausch Health Companies, Inc., Merck & Co. Inc., Allergen Inc., Novartis International AG, Johnson & Johnson Private Limited, GlaxoSmithKline Plc and Purdue Pharma L.P, etc.

Key Questions Answered in This Report:

  • 1. What was the global pain management drugs market size in 2020?
  • 2. What are the key global pain management drugs market drivers?
  • 3. Who are the leading pain management drug manufacturers?
  • 4. What is the pain management drugs market breakup by distribution channel?
  • 5. How will the global pain management drugs market perform over the next five years (2021-2026)?
  • 6. What is the leading drug class in the global pain management drugs market?
  • 7. What is the major indication in the global pain management drugs market?
  • 8. What are the major trends in the global pain management drugs market?
  • 9. What is the impact of COVID-19 on the global pain management drugs market?
  • 10. What are the major regions in the global pain management drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pain Management Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Drug Class
  • 5.5 Market Breakup by Indication
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 NSAIDs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Anesthetics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Anticonvulsants
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Antimigraine Agents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Antidepressants
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Opioids
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Musculoskeletal Pain
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Surgical and Trauma Pain
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cancer Pain
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Neuropathic Pain
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Migraine Pain
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Obstetrical Pain
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Fibromyalgia Pain
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Burn Pain
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Dental/Facial Pain
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast
  • 7.10 Pediatric Pain
    • 7.10.1 Market Trends
    • 7.10.2 Market Forecast
  • 7.11 Others
    • 7.11.1 Market Trends
    • 7.11.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories, Inc.
    • 14.3.2 Pfizer, Inc.
    • 14.3.3 Eli Lilly & Company
    • 14.3.4 Endo International plc
    • 14.3.5 F. Hoffmann-La Roche AG
    • 14.3.6 Bausch Health Companies, Inc.
    • 14.3.7 Merck & Co. Inc.
    • 14.3.8 Allergen Inc.
    • 14.3.9 Novartis International AG
    • 14.3.10 Johnson & Johnson Private Limited
    • 14.3.11 GlaxoSmithKline Plc
    • 14.3.12 Purdue Pharma L.P
Back to Top
전화 문의
F A Q